Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data
Markets Daniel Marsh

Abbott Shares Gain on Insider Purchase and Positive Cardiac Device Data

Abbott Laboratories stock rose 1.6% Friday following a director's $1.09 million share purchase and new clinical data for its heart rhythm devices presented at a medical symposium.

ABT
Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show
Regulation James Calloway

Disney Shares Face Regulatory Scrutiny as FCC Probes ABC Talk Show

Walt Disney Co's stock will be monitored Monday after U.S. regulators launched an investigation into ABC's 'The View' regarding election airtime rules. Shares closed Friday at $108.70, up 3.6%.

DIS
Texas Instruments Slashes Capex, Eyes Silicon Labs Deal Amid Insider Sales
Technology Sarah Chen

Texas Instruments Slashes Capex, Eyes Silicon Labs Deal Amid Insider Sales

Texas Instruments shares fell 1.13% as the company plans to cut 2026 capital spending to $2-3 billion and fund its Silicon Labs acquisition with cash and debt. Key executives sold shares after exercising options.

TXN
Boeing Shares Gain Amid Dow Milestone, Pentagon Review Looms
Markets Daniel Marsh

Boeing Shares Gain Amid Dow Milestone, Pentagon Review Looms

Boeing stock rose 2.6% as the Dow closed above 50,000 for the first time. Investors await a Pentagon list of underperforming defense contractors that could restrict shareholder payouts.

BA RTX LMT NOC GD XLI DIA
Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats
Regulation James Calloway

Novo Nordisk Rebounds as FDA Vows Crackdown on Wegovy Copycats

Novo Nordisk B shares surged 5.29% after Hims & Hers halted its $49 compounded version of Wegovy, with the FDA pledging action against unauthorized copycats. The stock remains down roughly 20% over five sessions amid pricing uncertainty.

NVO LLY HIMS
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Earnings James Calloway

Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead

Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.

AMGN CVS DOW SPY XLV
Linde Shares Face Pressure After JPMorgan Downgrade, Focus Turns to Pricing Outlook
Analysis Daniel Marsh

Linde Shares Face Pressure After JPMorgan Downgrade, Focus Turns to Pricing Outlook

Linde stock fell 2.53% to $448.07 Friday after JPMorgan cut its rating to Neutral, citing valuation and flat sequential pricing. Investors await U.S. jobs data and company conferences this week.

LIN APD JPM UBS MS C BAC XLI
Inditex Initiates Share Repurchase Ahead of March Earnings
Earnings James Calloway

Inditex Initiates Share Repurchase Ahead of March Earnings

Inditex shares edged higher Friday after announcing a €180 million buyback program for employee incentives, with full-year results due March 11.

BBVA
Thermo Fisher Shares End Week Lower Amid Research Funding Concerns
Earnings James Calloway

Thermo Fisher Shares End Week Lower Amid Research Funding Concerns

Thermo Fisher Scientific closed Friday at $542.83, down 6.7% for the week as investors weigh pressure from academic research funding cuts. The company's 2026 outlook projects adjusted earnings of $24.22 to $24.80 per share.

TMO DHR BDX STE
GE Vernova Surges 5.6% as Energy Infrastructure Demand Fuels Rally
Markets Daniel Marsh

GE Vernova Surges 5.6% as Energy Infrastructure Demand Fuels Rally

GE Vernova shares climbed to $779.35 amid a broader market rally, buoyed by new wind orders and a strategic alliance. Analysts highlight the early-stage energy infrastructure cycle but note wind segment risks.

GEV XLE XLK
MUFG Shares Surge as Japan Election Outcome Fuels Bond Yield and Yen Speculation
Markets Daniel Marsh

MUFG Shares Surge as Japan Election Outcome Fuels Bond Yield and Yen Speculation

Mitsubishi UFJ Financial Group's stock rose sharply following Prime Minister Sanae Takaichi's election victory, reigniting market bets on higher bond yields and a weaker yen. Traders are closely monitoring Bank of Japan signals and bank bond portfolio risks.

MUFG
Shell Halts Kazakhstan Investments Amid Legal Disputes, Posts Mixed Q4 Results
Markets Daniel Marsh

Shell Halts Kazakhstan Investments Amid Legal Disputes, Posts Mixed Q4 Results

Shell paused new Kazakhstan investments due to legal disputes over project costs, reported $3.3B Q4 profit below estimates, and will switch auditors to PwC from 2027. Shares edged up 0.2%.

SHEL USO